Paydirt
BB
Insider

Bruce Booth

Director

Bruce Booth (Director) filed 16 Form 4 reports in the trailing twelve months (0 purchases, 16 sales, 1 filed past the two-business-day deadline), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $56.3M of KYMR (511,764 sh across 27 lots, as filed), executed Jun 26.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
16
0 buys · 16 sells · 1 late
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$246.6M
shares × price, as filed
Last traded
Jun 29
Filed Jul 2

Median ADV $102.3M across their filed names

Open performance
Volume by month
$186.4M$93.2M$0Oct 2024Apr 2025Oct 2025Apr 2026Feb 2025 · buys $1.1MOct 2025 · sells $21.7MDec 2025 · sells $21.5MMar 2026 · sells $7.4MApr 2026 · sells $1.4MJun 2026 · sells $186.4MJul 2026 · sells $8.2M
Buys $1.1M Sells $246.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 16 filings

Sector per market data · by filing · past 12 months

Most traded names
KYMR Kymera Therapeutics, Inc. KYMR · 0 buys · 11 sells 11 filings SION Sionna Therapeutics, Inc. SION · 1 buy · 5 sells 6 filings
Recent filings
KYMRSALE Kymera Therapeutics, Inc. View filing → $8.2M
75,750 sh across 12 lots
Exec Jun 29
Filed Jul 2 · 5:39 PM ET †
KYMRSALE Kymera Therapeutics, Inc. View filing → $3.4M
31,126 sh across 7 lots
Exec Jun 29
Filed Jun 30 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $56.3M
511,764 sh across 27 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $34.5M
283,553 sh across 16 lots
Exec Jun 25
Filed Jun 25 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $43.8M
396,626 sh across 22 lots
Exec Jun 23
Filed Jun 25 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $3.3M
31,798 sh across 4 lots
Exec Jun 22
Filed Jun 22 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $45.1M
476,201 sh across 26 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET
KYMRSALE Kymera Therapeutics, Inc. View filing → $531K
5,900 sh × $89.96
Exec Apr 22
Filed Apr 24 · 5:30 PM ET
More filings →